Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001

Go back to Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001
(NASDAQ: PGEN) Delayed: 5.36 -0.02 (0.37%)
Previous Close $5.38    52 Week High
Open $5.29    52 Week Low
Day High $5.59    P/E N/A 
Day Low $5.27    EPS
Volume 5,246,902